http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019223730-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d52e76abfb03fea5220bda586463d9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2560-0223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14551
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-349
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2019-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f856423a83b5aa19981db6cab09e9982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bd479924c5e7e40a75b28ecd7c88157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13bf4073b00c7b6c8433edf48abca8fe
publicationDate 2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019223730-A1
titleOfInvention Contactless System and Method For Assessing Tissue Viability and Other Hemodynamic Parameters
abstract A contactless system for assessing tissue viability and other hemodynamic parameters includes one or more light sources configured to emit lights at a predetermined wavelength sensitive to hemoglobin concentration associated with spontaneous hemodynamic oscillations at tissue in a predetermined area of a human subject. One or more polarizers are each coupled to one or more of the one or more light sources and are configured to polarize the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth and the polarized light is maintained in the polarized state at the predetermined depth. One or more detectors each including a detector polarizer coupled thereto are configured to discriminate the light maintained in the polarized state and at the predetermined depth and are configured to generate a plurality of frames of the tissue in the predetermined area at the predetermined depth. A controller is coupled to the one or more light sources and the one or more detectors. The controller is configured to: acquire the plurality of frames, select a region of interest having the same coordinates for each of the plurality of frames, average the number of pixels within each region of interest to create a raw reference signal, detrend the raw reference signal to create a detrended raw reference signal, perform frequency domain analysis of the detrended raw reference signal, identify a frequency band of interest associated with the spontaneous hemodynamic oscillations, and perform an inverse fast Fourier transform within the frequency band of interest to generate a reference signal indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation. For each sample of the reference signal at a predetermined point in time, the controller multiplies the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time. The controller adds the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue in the predetermined area.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021150305-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023018846-A1
priorityDate 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412

Total number of triples: 31.